ICR Hosts Vaxxinity CEO Mei Mei Hu on the Welcome to the Arena Podcast

Rhea-AI Summary

Vaxxinity, Inc. (Nasdaq: VAXX), a pioneer in immunotherapeutic vaccines, was featured in Episode 64 of ICR’s podcast, "Welcome to the Arena." CEO Mei Mei Hu discussed the company's origins and its commitment to developing vaccines for chronic diseases, emphasizing the goal of increased accessibility. ICR, established in 1998, specializes in strategic communications and advisory services, partnering with around 1,000 clients. The podcast has been ongoing since August 2021, airing bi-weekly, and covers a range of topics relevant to public and private equity sectors.

Positive

• CEO Mei Mei Hu featured on a prominent podcast improves visibility for Vaxxinity.
• Discussion about vaccine accessibility aligns with current healthcare trends and demands.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- ICR, a leading strategic communications and advisory firm, is pleased to announce that Mei Mei Hu, Chief Executive Officer and Co-Founder, Vaxxinity, Inc. (Nasdaq: VAXX), a U.S. company pioneering the development of a new class of immunotherapeutic vaccines, recently appeared on Episode 64 of ICR’s “Welcome to the Arena” podcast.

Welcome to the Arena is hosted by Tom Ryan, Co-Founder & CEO of ICR. Tom spoke with Mei Mei about Vaxxinity's origin, their approach to developing vaccines for prevalent chronic diseases, their mission to make vaccines more accessible, and more.

The Welcome to the Arena podcast has featured discussions with CEOs, CFOs, financial analysts, members of the media, investment bankers, private equity executives and others who influence and create value for public and private-equity backed companies. The podcast made its debut in August 2021, airing episodes roughly every two weeks, and is available on Apple Podcasts, Spotify, Google Podcasts, or anywhere else you get your podcasts.

About ICR

Established in 1998, ICR partners with its clients to execute strategic communications and advisory programs that achieve business goals, build awareness and credibility, and enhance long-term enterprise value. The firm’s highly-differentiated service model, which pairs capital markets veterans with senior communications professionals, brings deep sector knowledge and relationships to approximately 1,000 clients across more than 20 industry groups. ICR’s healthcare practice operates under the Westwicke brand (www.westwicke.com). Today, ICR is one of the largest and most experienced independent communications and advisory firms in North America, maintaining offices in New York, Norwalk, Boston, Baltimore and Beijing. Learn more at www.icrinc.com. Follow us on Twitter at @ICRPR.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230301005692/en/

Brian Ruby, ICR, 203-682-8268, brian.ruby@icrinc.com

Source: ICR

FAQ

What was discussed in Vaxxinity's segment on ICR's podcast?

CEO Mei Mei Hu talked about Vaxxinity's origins and its approach to developing vaccines for chronic diseases.

When did Vaxxinity appear on the Welcome to the Arena podcast?

Vaxxinity appeared on Episode 64 of the podcast.

What is Vaxxinity's focus in vaccine development?

Vaxxinity focuses on developing immunotherapeutic vaccines for prevalent chronic diseases.

When did the Welcome to the Arena podcast start airing?

The podcast debuted in August 2021 and features episodes roughly every two weeks.

Who hosts the Welcome to the Arena podcast?

The podcast is hosted by Tom Ryan, Co-Founder & CEO of ICR.